Dr Jacobs Promo 1

https://youtu.be/ql9NV9sCsHQ
http://www.givepainavoice.org/

givepainavoice

Give pain a voice Promo One

https://youtu.be/7Aph17MtUro

http://www.givepainavoice.org/

givepainavoice

This is from SIX YEARS AGO… somethings NEVER CHANGE :-(

golden living nursing homes – “bad care” spotlight ?

http://abc27.com/2016/04/19/raw-video-abc27-has-tough-questions-for-golden-living-president/

Raw Video: ABC27 has tough questions for Golden Living president

I’ve been hacked- email

my email got hacked and they locked my account … Trying to get it unlocked .. Not a quick process 🙁

i have alternative email if you need to reach me

ariens@twc.com

 

 

UnitedHealth pulling out of most ObamaCare markets

UnitedHealth pulling out of most ObamaCare markets

http://thehill.com/policy/healthcare/276787-unitedhealth-pulling-out-of-most-obamacare-markets

The insurer UnitedHealth is pulling out of the ObamaCare marketplaces in all but a “handful” of states in 2017, the company announced Tuesday.

The announcement, made by CEO Stephen Hemsley on an earnings call, follows up on the company’s statement in November that it was considering dropping out completely due to financial losses.

The moves by United, the nation’s largest health insurer, have drawn attention for what they could indicate about the sustainability of ObamaCare as whole.

But as the Obama administration has pointed out, United is actually a fairly small player on the ObamaCare marketplaces, with about 6 percent of enrollees. It also often was not priced competitively.

Still, United is far from alone among insurers in having concerns about financial losses in the ObamaCare marketplaces.

Some insurers that play a larger role in the program, such as Blue Cross Blue Shield plans in some states, have also raised the prospect of dropping off the marketplaces.

Significant premium increases are widely expected for next year as insurers try to stop their losses, though the impact for consumers is usually cushioned by ObamaCare’s tax credits.

The administration says it expects that insurers will both come and go as the new market set up by the law develops, but that the marketplace will continue to succeed.

“The Marketplace is a reliable source of coverage for millions of Americans with a robust number of plan choices,” Department of Health and Human Services spokesman Ben Wakana said in a statement. “We have full confidence, based on data, that the Marketplaces will continue to thrive for years ahead.”

Still, a Kaiser Family Foundation study on Monday found that if United pulled out of all of the 34 states in which it participated in 2016, the number of choices for consumers would decline. But premiums would not be affected greatly because United often does not offer one of the cheapest plans.

Discriminating against pain…. OK ??? …but if you have HIV… good to go ??

http://www.ada.gov/pmc/pain_mgmt_care_complaint.html

IN THE UNITED STATES DISTRICT COURT
FOR THE NORTHERN DISTRICT OF INDIANA
FORT WAYNE DIVISION

UNITED STATES OF AMERICA,

Plaintiff,

v.

PAIN MANAGEMENT CARE, P.C.,

Defendant.

 

CIVIL ACTION NO.

COMPLAINT

THE UNITED STATES OF AMERICA respectfully alleges:

  1. This action is brought by the United States of America (hereinafter “Plaintiff”) to enforce Title III of the Americans with Disabilities Act of 1990, as amended (“ADA”), 42 U.S.C. §§ 12181-89, and its implementing regulation, 28 C.F.R. Part 36, against Pain Management Care, P.C. (hereinafter “Defendant” or “PMC”). Defendant violated the ADA when it refused to treat Ralph Hardin, an individual with HIV, because of Mr. Hardin’s HIV.
  2. The Attorney General has commenced this action based on a determination that a person or group of persons has been discriminated against and that such discrimination raises an issue of general public importance. 42 U.S.C. § 12188(b)(1)(B). The United States seeks declaratory and injunctive relief, compensatory damages, and a civil penalty against Defendant.
  3. This Court has jurisdiction over this action under 42 U.S.C. § 12188(b)(1)(B) and 28 U.S.C. §§ 1331 and 1345.
  4. The Court may grant declaratory relief and further necessary or proper relief pursuant to 28 U.S.C. §§ 2201 and 2202 and may grant equitable relief, monetary damages, and a civil penalty pursuant to 42 U.S.C. § 12188(b)(2).
  5. Venue is proper in the Northern District of Indiana pursuant to 28 U.S.C. § 1391(b)(2) because a substantial part of the events or omissions giving rise to the claim occurred in this district.
  6. Defendant is an Indiana-based Professional Corporation located at 2106 Ironwood Circle, South Bend, Indiana, 46635. Defendant provides interventional pain management treatment through anesthesiologist and pain management specialist Dr. Joseph Glazier at two clinical locations: 2106 Ironwood Circle, South Bend, Indiana, 46635, and 707 North River Drive #C, Marion, Indiana, 46952.
  7. Defendant is a public accommodation within the meaning of 42 U.S.C. § 12181(7).
  8. Ralph Hardin was referred to PMC for pain management care in or about November 2014 upon the closure of his prior pain management care provider’s office.
  9. Ralph Hardin has a disability within the meaning of 42 U.S.C. § 12102 and 28 C.F.R. § 36.104. He has HIV, which is an impairment that substantially limits one or more major life activity, including the functions of the immune system, which is a major bodily function.
  10. Mr. Hardin’s treatment referral was for therapeutic injections, informally known as “cortisone shots,” which was the pain management treatment he had been receiving previously on a bi-monthly basis.
  11. In or about November 2014, Mr. Hardin first contacted PMC regarding his interest in receiving treatment at PMC’s Marion clinic location.
  12. Mr. Hardin spoke with Linda Glazier, a PMC employee, who requested preliminary documentation relevant to the treatment he was seeking, including medical records and other documentation.
  13. Mr. Hardin provided documentation including paperwork from his previous pain management care treatment provider, a compact disk with a copy of an MRI scan relevant to the pain he was having, and other medical records.
  14. Ms. Glazier followed up with Mr. Hardin to confirm receipt of the documentation and informed him that Dr. Joseph Glazier, an anesthesiologist and pain management specialist, and the sole treatment provider at the clinic locations, would contact him after reviewing his records.
  15. On or about November 20, 2014, Ms. Glazier left Mr. Hardin a voicemail message stating that PMC would not treat him “due to the risks involved with needles and blood due to [his] condition of being HIV positive.”
  16. Shortly after receiving the message, Mr. Hardin contacted Ms. Glazier via telephone to request that PMC change its position and agree to provide treatment.
  17. PMC continued to deny treatment to Mr. Hardin after the aforementioned request.
  18. Following PMC’s denial, Mr. Hardin actively searched for treatment providers in his geographic vicinity that could provide him pain management care, but was not able to find such a provider until June 2015.
  19. PMC’s discriminatory denial caused Mr. Hardin to endure over six months without needed pain management care and to experience emotional distress.

CAUSE OF ACTION

Title III of the Americans with Disabilities Act

  1. The allegations of the foregoing paragraphs are hereby re-alleged and incorporated by reference as if fully stated herein.
  2. Mr. Hardin is an individual with a disability because he has an impairment that substantially limits one or more major life activities.
  3. PMC discriminated on the basis of disability in the full and equal enjoyment of its goods, services, facilities, privileges, advantages, or accommodations in violation of Title III of the ADA, 42 U.S.C. § 12182(a), and the Title III implementing regulation at 28 C.F.R. Part 36, by:
    1. denying an individual or class of individuals, on the basis of disability, the ability to participate in or benefit from its goods, services, facilities, privileges, advantages, or accommodations by refusing to provide pain management treatment, in violation of 42 U.S.C. § 12182(b)(1)(A)(i) and 28 C.F.R. § 36.202;
    2. using standards or criteria or methods of administration that have the effect of discriminating on the basis of disability, in violation of 42 U.S.C. § 12182(b)(1)(D) and 28 C.F.R. § 36.204; and
    3. imposing or applying eligibility criteria that screen out, or tend to screen out, an individual with a disability or class of individuals with disabilities from fully and equally enjoying PMC’s goods, services, facilities, privileges, advantages, or accommodations, in violation of 42 U.S.C. § 12182(b)(2)(A)(i) and 28 C.F.R. § 36.301(a).
  4. Defendant has discriminated against a person or group of persons and that raises an issue of general public importance under 42 U.S.C. § 12188(b)(1)(B)(ii).
  5. As a result of Defendant’s discriminatory conduct, Mr. Hardin suffered physical pain and emotional distress. Mr. Hardin and other persons who may have been the victims of Defendant’s discriminatory practices are aggrieved persons under 42 U.S.C. § 12188(b)(2)(B).

Prayer For Relief

WHEREFORE, the Plaintiff United States prays that the Court:

  1. Grant judgment in favor of the United States and declare that Defendant violated Title III of the ADA, 42 U.S.C. §§ 12181-89, and its implementing regulation, 28 C.F.R. Part 36;
  2. Order Defendant, its officers, agents, employees, and all others in concert or participation with it, to comply with the requirements of Title III of the ADA, 42 U.S.C. §§ 12181-89, and its implementing regulation, 28 C.F.R. Part 36;
  3. Order Defendant to take such affirmative steps as may be necessary to restore, as nearly as practicable, Ralph Hardin and other aggrieved persons to the position that they would have been in but for Defendant’s conduct;
  4. Award compensatory damages, including damages for pain, suffering, and emotional distress, to aggrieved persons under 42 U.S.C. § 12188(b)(2)(B), for injuries suffered as the result of Defendant’s violations of Title III of the ADA, 42 U.S.C. §§ 12181-89, and its implementing regulation, 28 C.F.R. Part 36;
  5. Assess a civil penalty against Defendant in the maximum amount authorized by 42 U.S.C. § 12188(b)(2)(C), to vindicate the public interest; and
  6. Order such other appropriate relief as the interests of justice may require.

Respectfully submitted this 7th day of April, 2016.

FOR THE UNITED STATES OF AMERICA:

LORETTA E. LYNCH
Attorney General of the United States

DAVID A. CAPP
United States Attorney
Northern District of Indiana

 

 

 

 

 

 

 

 

/s/ Deborah Leonard
DEBORAH LEONARD
Assistant U.S. Attorney
Northern District of Indiana
United States Attorney’s Office
5400 Federal Plaza, Suite 1500
Hammond, IN  46320
(219) 937-5500
deborah.leonard@usdoj.gov

/s/ Vanita Gupta
VANITA GUPTA
Principal Deputy Assistant Attorney General

EVE L. HILL
Deputy Assistant Attorney General
Civil Rights Division

 

/s/ Rebecca B. Bond
REBECCA B. BOND
Chief
KATHLEEN P. WOLFE
Special Litigation Counsel
AMANDA MAISELS
Deputy Chief
Disability Rights Section
Civil Rights Division

 

/s/ David W. Knight
DAVID W. KNIGHT
Trial Attorney
Disability Rights Section
Civil Rights Division
U.S. Department of Justice
950 Pennsylvania Avenue, N.W. – NYA
Washington, DC  20530
202-616-2110
david.knight@usdoj.gov

Rx only MMJ coming… ONLY $5000/month ?

Medical pot activists fear new Epilepsy drug will undercut them

 http://www.digitaljournal.com/life/health/medical-pot-activists-fear-new-epilepsy-drug-will-undercut-them/article/463097#ixzz4685wfzHT

The manufacturer of a new drug made from marijuana, and used to treat a rare form of epilepsy, is going to seek approval from the U.S. Food and Drug Administration. But medical marijuana activists are fearful FDA approval will hurt them politically.

G W Pharmaceuticals is the maker of Epidiolex, an almost pure extract of cannabidiol, or CBD. The drug contains very little tetrahydrocannabinol, or THC, that gives marijuana users a high.

 

The CBD in medical pot products are what is fueling the current rage today, and activists are fearful that if the FDA does approve Epidiolex for use, the move will adversely affect the political momentum of the medical marijuana movement. The drug company says that if Epidiolex is approved, it will be the first drug in the U.S. containing CBD to get approval.

 

The Associated Press reports that Dr. Anup Patel, a pediatric neurologist who oversees Epidiolex clinical trials at Nationwide Children’s Hospital in Columbus, Ohio, points out the drug contains the optimal known amount of CBD for treating seizures. He also cited a study that found children can be hurt by using the whole plant.

 

Patel went on to say that the thing that upsets him the most is that children are being used to push for medical marijuana legalization in the U.S., even though Ohio knocked legalization down when it was on the ballot last year. “People are mixing terms, mixing ideas,” the Herald Online quoted him as saying. “I’m not sure if that’s just because of confusion, lack of knowledge or on purpose.”

 

Two warring camps on the issue of medical marijuana

 

One camp or side of the issue is the opinion held by traditional medical marijuana users. They say that an individual knows what is best for them, regardless of if they smoke, use an oil vaporizer pen or use flowered products or the oil. As activists, they want to protect their ability to do just that.

 

This is why they are afraid of the big pharmaceutical companies getting involved in medical marijuana because they would lose the right to dose themselves. But they are ignoring the people, such as children and the elderly, that really can benefit from the extracts of marijuana, who may not know how or be able to make the concentrations themselves.

 

The other camp in this issue wants to see more scientific validity and real studies done on the optimal concentrations needed in dosing. They say this will give reliability to the products. They also point out the cost of medical marijuana products, which cost from about $100 to more than $1,000 per month. These costs are not covered by most medical insurance policies, but a drug like Epidiolex, which would cost from $2,500 to $5,000 a month, could be covered by most insurance policies.

 

Epidiolex has proven to be an effective treatment for one rare form of epilepsy called Dravet Syndrome and is just one in a line of marijuana-based medications on the market. G W Pharmaceuticals also manufactures Sativex, a drug that treats multiple sclerosis spasticity. Sativex contains a specific extract of Cannabis, nabiximols, that was approved as a botanical drug in the United Kingdom in 2010 as a mouth spray.

 

The bottom line for this issue is that activists fear Epidiolex approval will mark the beginning of Big Pharma’s takeover of the marijuana plant, taking away a patient’s ability to treat themselves as they see fit.

Always count your opiate/control doses ?

 

Employees stealing drugs from Ohio pharmacies, health care facilities

http://www.dispatch.com/content/stories/local/2016/04/17/employees-stealing-drugs-from-pharmacies-health-care-facilities.html

TORONTO, Ohio — Time and again, customers called the Toronto Apothecary to complain after picking up their prescriptions. It was always the same story: Pills were missing from the bottles.

Workers figured the customers had to be wrong. Pharmacists insisted they had double-counted the pills.

Soon enough, though, they learned that their customers had been right.

A pharmacy technician regularly was dropping vials of oxycodone on the floor at the cash register. When she bent to retrieve them, she skimmed a few of the addictive painkillers for herself.

It’s just one example of yet another side effect of the country’s destructive prescription-drug addiction: health care professionals and workers who pilfer drugs to feed their own habits.

“You see it happening all over the place,” said owner and pharmacist Joe Amaismeier, whose Toronto Apothecary is tucked into a strip mall in this Rust Belt town of 5,000 near Steubenville.

He fired the technician, who was linked to $200 in losses at that store and $100 in missing medication at a now-defunct drugstore 12 miles away in Wellsville.

To understand the magnitude of the problem of internal drug theft, The Dispatch analyzed hundreds of state records from multiple agencies and professional-licensing boards and found that:

• At least 217 health care employees in Ohio were implicated in prescription-drug thefts in 2014, according to data from the state Board of Pharmacy and the Drug Enforcement Administration. Some employees were so addicted that they used the stolen drugs at work, their impairment putting the safety of patients at risk.

• On average, at least one health care worker in Ohio every other day is charged in court or loses a job or professional license as a result of theft. No one knows the exact number because experts agree internal thefts are underreported.

• Not surprisingly, the most addictive prescription medications were the most targeted for internal theft: oxycodone, hydrocodone, hydromorphone, morphine and Fentanyl.

• Few safeguards exist to prevent pharmacy technicians, a largely unregulated field, from stealing drugs, then getting a job at another pharmacy.

The details of the cases, culled from a variety of court records, police investigations and licensing-board reports, are troubling:

A Rite Aid pharmacist from northeastern Ohio had seizures while in the store’s bathroom after he overdosed on stolen tramadol. A nurse anesthetist in Springfield tried to kill himself by injecting stolen pain medications at work. A pharmacist at a Downtown Columbus CVS stole at least four pain medications and was caught on camera taking the pills. A Powell doctor repeatedly over-ordered hydrocodone for his practice and then took it himself.

The state Board of Nursing recently added two investigators (it now has 12) to keep up with cases of wrongdoing.

“It has been a problem, and we see it increasing as a problem,” Executive Director Betsy Houchen said.

•    •    •

Professional licensing boards can — and do — take action against health care workers who are caught stealing drugs or who admit addictions. But another group with ready access to drugs remains largely unregulated: pharmacy technicians.

They can exploit a loophole in Ohio’s oversight of health care workers because there is little to prevent techs who steal drugs from getting a job at another pharmacy and stealing again.

There are two significant reasons why.

Ohio is one of eight states that do not license, register or certify pharmacy technicians, according to the National Association of Boards of Pharmacy. And most pharmacy technicians charged with prescription drug theft are granted treatment in lieu of conviction by a court. That means if they complete intensive therapy, counseling and probation, the criminal charge disappears.

Information about treatment-in-lieu-of-conviction cases sometimes shows up on background checks — for certain home health care workers, for instance. But information concerning pharmacy technicians who steal and then enter such treatment cannot be disclosed, according to a spokeswoman for the state attorney general’s office.

That would take a change in state law.

The State of Ohio Board of Pharmacy “is concerned about its lack of jurisdiction” over pharmacy technicians, said Steven Schierholt, the board’s executive director, and it is working toward a “viable solution.” But he did not provide any specifics.

No one disputes that the role of techs is an important one; they really are a pharmacist’s right hand. But with that responsibility comes access, and some are bound to abuse it.

For one 26-year-old North Side man, it started in 2014 with cough medicine with codeine.

As he raced around his evening shift at the CVS at Cleveland and Oakland Park avenues, he would grab a box full of promethazine doses from the shelf and discreetly drop it into the trash. Then he’d go about his work.

At the end of the night, he would take out the garbage. He knew there were no cameras behind the store, so he would quickly and quietly rip open the plastic bag, remove the box of medicine, slip what he needed for that night into his pocket, and throw the rest back in the trash.

No way he could just steal the whole box.

“The security guard checks our bags when we leave at the end of the shift,” he said in a recent interview. The Dispatch agreed to not use his name if he offered insights into the theft problem because he is in a treatment-in-lieu-of-conviction program. “You take just what you can get out in your pants.”

Pretty soon, he was using the same method to steal the narcotic painkiller tramadol, and then came Suboxone, a painkiller that’s also used to treat opiate addiction.

He said he knew what he was doing was wrong, but he was paid $10.85 an hour, after all, and had a host of health issues and no insurance. He figured, a couple of pills here, a dose or two there — who was it hurting?

“I had a choice of doing something about it by self-medicating or live with the pain,” he said.

Eventually, newly installed hidden cameras caught him, and authorities charged him last year with five counts of theft.

Documents that pharmacies or health care facilities are required to file with the DEA when drugs come up missing show the pharmacy where he worked reported a loss of $12,000 worth of drugs in 2014, the largest of any single-site loss in the state that year. Prosecutors said the man couldn’t be linked to all of that, though, and he was charged only with what could be proved.

CVS declined an interview and said in an email that such incidents are isolated.

The pharmacy board received reports of 52 pharmacy technicians who stole prescription medications from their employers in 2015. Since 2012, the board has investigated two pharmacy technicians for repeat offenses. But those cases likely represent a fraction of the number of pharmacy technicians losing their jobs for stealing prescription drugs.

“Most employers dismiss the employee instead of bringing charges forward,” said Carmen Catizone, executive director of the National Association of Boards of Pharmacy.

Many states report that pharmacy technicians are responsible for 50 to 80 percent of prescription drug thefts by pharmacy employees, he said.

In 2014, after pharmacists at the Medical Arts Pharmacy on Cleveland Avenue regularly came up short on alprazolam (often sold under the brand name Xanax), they installed surveillance cameras. Within two days, they had an answer.

Video showed a tech waiting until a pharmacist entered a back room. She then grabbed a stock bottle of alprazolam, dumped pills into an amber vial and stuffed it down the front of her pants. Less than an hour later, she seemed to recognize the new cameras and, an investigator noted, appeared to smile into one of them. The pharmacists contacted investigators, and two technicians ultimately were fired and prosecuted. Both received treatment in lieu of conviction.

But even before their cases were out of court, one of them was working again, this time at Maple Leaf Pharmacy on West Broad Street. That pharmacy also began reporting shortages of Xanax. Records show there was an investigation but no charges filed. The tech was again fired.

Still, not everyone is convinced that techs should be registered, licensed or certified.

State Sen. Dave Burke, a Republican from Marysville who owns and runs a pharmacy there, said he thinks employee theft is minimal. “And I believe it’s been decreasing over time.”

Pharmacy technicians already must take a national test or one approved by the state’s Board of Pharmacy before they can work at a pharmacy, he said.

“I am always leery to impose a law on 0.01 percent of offenders that affects (the other) 99.9 percent,” Burke said.

Pharmacists would be more likely to support the idea of registering pharmacy technicians, though the devil is in the details, said Ernest Boyd, executive director of the Ohio Pharmacists Association. In that case, a technician accused of theft could be flagged and not allowed to work in a pharmacy until the matter is resolved.

•    •    •

At least 34 percent of employee drug thefts in Ohio analyzed by The Dispatch occurred in post-acute and long-term care facilities. The actual percentage could top 40 percent.

In April 2014, a police officer pulled over a car and discovered boxes in the back filled with medication intended for Alzheimer’s patients at a long-term care facility in Dayton. A worker accused of theft told officials that she “accidentally took the medications and didn’t notice that they were in her car,” according to a document on file with the Ohio Department of Health.

That was one of the more unusual cases handled by the department, which in 2015 barred 37 people from working in long-term care facilities as a result of workplace drug theft.

More common are thefts such as one in March 2014 at a Canton assisted living facility. There a licensed practical nurse reported that a resident had been given six tablets of hydrocodone for pain relief during an eight-hour shift. The resident, however, told the director of nursing that she did not receive any.

The patient’s urine tested negative for narcotics; the health care worker accused of wrongfully taking medication refused a drug test.

In many cases, the only way such theft is discovered is if officials notice that a patient’s pain coincides with a particular caregiver’s shift, said Peter Van Runkle, executive director of the Ohio Health Care Association, a nursing home industry group. That could indicate that the caregiver might be diverting prescription medications instead of giving them to patients.

“It’s been around forever and probably will continue to be,” Van Runkle said of employee theft.

Federal officials in recent years have alerted health care providers to tactics commonly used by prescription-drug thieves, such as retrieval of used Fentanyl patches from the trash. Some nurses even remove the patches from patients prematurely, place them on themselves, then stick them back on the patient before the patch is checked again, Van Runkle said.

“Where there’s a will, there’s a way,” said Brandon Webb, the new administrator of the London Health & Rehab Center, formerly known as the Arbors at London. The nursing home reported a theft of Percocet, oxycodone and other controlled drugs by an employee in March 2015.

Webb said two nurses are required to count medications together when they close out a medication cart. “There’s lots of checks and balances,” he said.

Hospitals, meanwhile, accounted for 29 percent of all employee thefts of prescription drugs, according to the Dispatch analysis.

Typical cases include a night nurse at OhioHealth Dublin Methodist Hospital who disappeared during his shift and was later found “sprawled across a chair intended for visitor use.” He admitted to stealing morphine intended for a patient. Another nurse there stole a patient’s Fentanyl and injected it into his own arm while on duty.

Despite those and other internal drug thefts at OhioHealth hospitals, officials said they haven’t seen any pattern that would prompt a change in procedures.

The hospital system monitors for suspicious drug withdrawals from dispensing cabinets and uses surveillance. There’s also an education component to help employees identify warning signs of drug diversion and addiction. There’s a culture of “see something, say something,” officials said.

But workers who steal drugs can be challenging to catch, in part because they have legitimate access to medications.

“They are familiar with the working environment, with the equipment and procedures, and also with their fellow workers and their routines,” Harry Trombitas, OhioHealth’s vice president of security operations, wrote in a statement. “They can plan their actions and be very secretive about it.”

Smaller hospitals also deal with the problem. Berger Hospital in Circleville experienced a series of related employee thefts of hydrocodone and Oxycontin from its pharmacy in 2014. Since then, administrators have installed security cameras and automated dispensing cabinets for medications.

Those cabinets are audited randomly, and the narcotics are reorganized periodically to make it harder for would-be thieves to memorize the location of frequently abused opiates. No employee can access the narcotics safe alone.

The tactics used by internal thieves evolve over time, said Kristin Gardner, Berger’s chief nursing officer: “The challenge is that you don’t always know what you don’t know.”

As authorities work to crack down on the epidemic of drug abuse, the court system has evolved in recent years to give a second chance to those accused of prescription theft.

“An opiate addiction is something that will grab you by the throat and drag you around and make you do things you otherwise wouldn’t do,” said Stephen Palmer, a prominent Columbus defense attorney whose clients include many health care professionals.

“Addiction doesn’t discriminate.”

My Name is FIBRO !